Clinical application of mesenchymal stem cells in the treatment and prevention of graft-versus-host disease

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Lin, Yi ^a   Hogan, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALEMTUZUMAB; BUSULFAN; CARMUSTINE; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD79 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ENDOGLIN; ETOPOSIDE; FLUDARABINE; HLA DR ANTIGEN; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THIOPENTAL; THY 1 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; B LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CHRONIC GRAFT VERSUS HOST DISEASE; DRUG DOSE TITRATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MORBIDITY; MORTALITY; NATURAL KILLER CELL; OSTEOBLAST; PRIORITY JOURNAL; REVIEW; SURVIVAL; T LYMPHOCYTE; TREATMENT RESPONSE; WHOLE BODY RADIATION;

EID: 84862952653     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/427863     Document Type: Review

References (46)

1. Horwitz E. M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F. C., Deans R. J., Krause D. S., Keating A., Clarification of the nomenclature for MSC: the international society for cellular therapy position statement Cytotherapy 2005 7 5 393 395 (Pubitemid 41671625)
2. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement Cytotherapy 2006 8 4 315 317 (Pubitemid 44269669)
3. Selmani Z., Naji A., Zidi I., Favier B., Gaiffe E., Obert L., Borg C., Saas P., Tiberghien P., Rouas-Freiss N., Carosella E. D., Deschaseaux F., Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25 high FOXP3 + regulatory T cells Stem Cells 2008 26 1 212 222
4. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Experimental Hematology 2002 30 1 42 48 (Pubitemid 34059216)
5. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P. D., Matteucci P., Grisanti S., Gianni A. M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 2002 99 10 3838 3843 (Pubitemid 34534559)
6. Le Blanc K., Tammik L., Sundberg B., Haynesworth S. E., Ringden O., Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scandinavian Journal of Immunology 2003 57 1 11 20 (Pubitemid 38019084)
7. Tse W. T., Pendleton J. D., Beyer W. M., Egalka M. C., Guinan E. C., Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 2003 75 3 389 397 (Pubitemid 36222968)
8. Aggarwal S., Pittenger M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 2005 105 4 1815 1822 (Pubitemid 40223708)
9. Meisel R., Zibert A., Laryea M., Gobel U., Dubener W., Dilloo D., Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation Blood 2004 103 12 4619 4621 (Pubitemid 38745993)
10. Jiang X. X., Zhang Y., Liu B., Zhang S. X., Wu Y., Yu X. D., Mao N., Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells Blood 2005 105 10 4120 4126 (Pubitemid 40656164)
11. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G. L., Pistoia V., Uccelli A., Human mesenchymal stem cells modulate B-cell functions Blood 2006 107 1 367 372 (Pubitemid 43053565)
12. Spaggiari G. M., Capobianco A., Becchetti S., Mingari M. C., Moretta L., Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation Blood 2006 107 4 1484 1490 (Pubitemid 43242385)
13. Kinnaird T., Stabile E., Burnett M. S., Lee C. W., Barr S., Fuchs S., Epstein S. E., Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote In Vitro and In Vivo arteriogenesis through paracrine mechanisms Circulation Research 2004 94 5 678 685 (Pubitemid 38387752)
14. Haynesworth S. E., Baber M. A., Caplan A. I., Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 Journal of Cellular Physiology 1996 166 3 585 592 (Pubitemid 26095485)
15. Majumdar M. K., Thiede M. A., Haynesworth S. E., Bruder S. P., Gerson S. L., Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages Journal of Hematotherapy and Stem Cell Research 2000 9 6 841 848 (Pubitemid 32110282)
16. Popp F. C., Eggenhofer E., Renner P., Slowik P., Lang S. A., Kaspar H., Geissler E. K., Piso P., Schlitt H. J., Dahlke M. H., Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate Transplant Immunology 2008 20 1-2 55 60
17. Ge W., Jiang J., Baroja M. L., Arp J., Zassoko R., Liu W., Bartholomew A., Garcia B., Wang H., Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance American Journal of Transplantation 2009 9 8 1760 1772
18. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., Cavinato R. A., Todeschini M., Solini S., Sonzogni A., Perico N., Remuzzi G., Noris M., Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells Journal of Immunology 2008 181 6 3933 3946
19. Yanez R., Lamana M. L., Garcia-Castro J., Colmenero I., Ramirez M., Bueren J. A., Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease Stem Cells 2006 24 11 2582 2591 (Pubitemid 44674320)
20. Sudres M., Norol F., Trenado A., Gregoire S., Charlotte F., Levacher B., Lataillade J. J., Bourin P., Holy X., Vernant J. P., Klatzmann D., Cohen J. L., Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice Journal of Immunology 2006 176 12 7761 7767 (Pubitemid 43849077)
21. Polchert D., Sobinsky J., Douglas G. W., Kidd M., Moadsiri A., Reina E., Genrich K., Mehrotra S., Setty S., Smith B., Bartholomew A., IFN- activation of mesenchymal stem cells for treatment and prevention of graft versus host disease European Journal of Immunology 2008 38 6 1745 1755
22. Ren G., Su J., Zhang L., Zhao X., Ling W., L'Huillie A., Zhang J., Lu Y., Roberts A. I., Ji W., Zhang H., Rabson A. B., Shi Y., Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression Stem Cells 2009 27 8 1954 1962
23. Ferrara J. L., Levine J. E., Reddy P., Holler E., Graft-versus-host disease The Lancet 2009 373 9674 1550 1561
24. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., Ringden O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells The Lancet 2004 363 9419 1439 1441 (Pubitemid 38586721)
25. Ringden O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lonnies H., Marschall H. U., Dlugosz A., Szakos A., Hassan Z., Omazic B., Aschan J., Barkholt L., Le Blanc K., Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease Transplantation 2006 81 10 1390 1397 (Pubitemid 43847148)
26. Muller I., Kordowich S., Holzwarth C., Isensee G., Lang P., Neunhoeffer F., Dominici M., Greil J., Handgretinger R., Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation Blood Cells, Molecules, and Diseases 2008 40 1 25 32 (Pubitemid 350199635)
27. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M. E., Remberger M., Dini G., Egeler R. M., Bacigalupo A., Fibbe W., Ringden O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study The Lancet 2008 371 9624 1579 1586 (Pubitemid 351626841)
28. Arima N., Nakamura F., Fukunaga A., Hirata H., MacHida H., Kouno S., Ohgushi H., Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study Cytotherapy 2010 12 2 265 268
29. Zhou H., Guo M., Bian C., Sun Z., Yang Z., Zeng Y., Ai H., Zhao R. C., Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report Biology of Blood and Marrow Transplantation 2010 16 3 403 412
30. Perez-Simon J. A., Lopez-Villar O., Andreu E. J., Rifon J., Muntion S., Campelo M. D., Sanchez-Guijo F. M., Martinez C., Valcarcel D., Del Canizo C., Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial Haematologica 2011 96 7 1072 1076
31. von Bonin M., Stolzel F., Goedecke A., Richter K., Wuschek N., Holig K., Platzbecker U., Illmer T., Schaich M., Schetelig J., Kiani A., Ordemann R., Ehninger G., Schmitz M., Bornhuser M., Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium Bone Marrow Transplantation 2009 43 3 245 251
32. Fang B., Song Y., Liao L., Zhang Y., Zhao R. C., Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease Transplantation Proceedings 2007 39 10 3358 3362 (Pubitemid 350251475)
33. Kebriaei P., Isola L., Bahceci E., Holland K., Rowley S., McGuirk J., Devetten M., Jansen J., Herzig R., Schuster M., Monroy R., Uberti J., Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease Biology of Blood and Marrow Transplantation 2009 15 7 804 811
34. Prasad V. K., Lucas K. G., Kleiner G. I., Talano J. A. M., Jacobsohn D., Broadwater G., Monroy R., Kurtzberg J., Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study Biology of Blood and Marrow Transplantation 2010 17 4 534 541
35. Reagan M. R., Kaplan D. L., Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems Stem Cells 2011 29 6 920 927
36. Parekkadan B., Milwid J. M., Mesenchymal stem cells as therapeutics Annual Review of Biomedical Engineering 2010 12 87 117
37. Lee S. T., Jang J. H., Cheong J. W., Kim J. S., Maemg H. Y., Hahn J. S., Ko Y. W., Min Y. H., Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype British Journal of Haematology 2002 118 4 1128 1131 (Pubitemid 35025980)
38. Lazarus H. M., Koc O. N., Devine S. M., Curtin P., Maziarz R. T., Holland H. K., Shpall E. J., McCarthy P., Atkinson K., Cooper B. W., Gerson S. L., Laughlin M. J., Loberiza F. R., Moseley A. B., Bacigalupo A., Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients Biology of Blood and Marrow Transplantation 2005 11 5 389 398 (Pubitemid 40542932)
39. Ball L. M., Bernardo M. E., Roelofs H., Lankester A., Cometa A., Egeler R. M., Locatelli F., Fibbe W. E., Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation Blood 2007 110 7 2764 2767 (Pubitemid 47523204)
40. Ning H., Yang F., Jiang M., Hu L., Feng K., Zhang J., Yu Z., Li B., Xu C., Li Y., Wang J., Hu J., Lou X., Chen H., The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study Leukemia 2008 22 3 593 599 (Pubitemid 351386730)
41. Zhang X., Li J. Y., Cao K., Lu H., Hong M., Qian S., Wu H., Liu P., Xu W., Cotransplantation of HLA-identical mesenchymal stem cells and hematopoietic stem cells in Chinese patients with hematologic diseases International Journal of Laboratory Hematology 2010 32 2 256 264
42. Le Blanc K., Samuelsson H., Gustafsson B., Remberger M., Sundberg B., Arvidson J., Ljungman P., Lonnies H., Nava S., Ringden O., Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells Leukemia 2007 21 8 1733 1738 (Pubitemid 47086763)
43. Gonzalo-Daganzo R., Regidor C., Martin-Donaire T., Rico M. A., Bautista G., Krsnik I., Fores R., Ojeda E., Sanjun I., Garcia-Marco J. A., Navarro B., Gil S., Snchez R., Panadero N., Gutierrez Y., Garcia-Berciano M., Perez N., Milln I., Cabrera R., Fernndez M. N., Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults Cytotherapy 2009 11 3 278 288
44. Baron F., Lechanteur C., Willems E., Bruck F., Baudoux E., Seidel L., Vanbellinghen J. F., Hafraoui K., Lejeune M., Gothot A., Fillet G., Beguin Y., Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning Biology of Blood and Marrow Transplantation 2010 16 6 838 847
45. Hoogduijn M. J., Crop M. J., Korevaar S. S., Peeters A. M. A., Eijken M., Maat L. P. W. M., Balk A. H. M. M., Weimar W., Baan C. C., Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin Transplantation 2008 86 9 1283 1291
46. Buron F., Perrin H., Malcus C., Hequet O., Thaunat O., Kholopp-Sarda M. N., Moulin F. T., Morelon E., Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an In Vitro study using human cells Transplantation Proceedings 2009 41 8 3347 3352